The clinical relevance of tumor RAS/TP53 dual mutation in early and metastatic colorectal cancer (CRC).

Jenny F. Seligmann; Enric Domingo; David J. Fisher; Faye Elliott; Louise Brown; Michel Seymour; Susan D. Richman; Philip Quirke; Rachel Butler; Helen Roberts

doi:10.1200/jco.2022.40.16_suppl.3540

The clinical relevance of tumor RAS/TP53 dual mutation in early and metastatic colorectal cancer (CRC).

Identifier:nobleid.org/w1/20260515/49DFBCFC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/49DFBCFC.svg?ark=w1%2F20260515%2F49DFBCFC)](https://nobleid.org/work/w1/20260515/49DFBCFC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

The clinical relevance of tumor RAS/TP53 dual mutation in early and metastatic colorectal cancer (CRC).

Identifier:nobleid.org/w1/20260515/49DFBCFC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/49DFBCFC.svg?ark=w1%2F20260515%2F49DFBCFC)](https://nobleid.org/work/w1/20260515/49DFBCFC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work